Institute researchers have developed a new multi-omics method enabling the profiling of multiple histone modifications and ...

Prognostic significance of PSA>0.2 after 6-12 months treatment for metastatic hormone-sensitive prostate cancer (mHSPC) intensified by androgen-receptor pathway inhibitors (ARPI): A multinational real ...